Bioibericas Veterinary Division was present at the ESVOT congress, held in Bologna (Italy) on 12-15 October, 2012
Bioibérica had an exhibit at the 2012 ESVOT (European Society of Veterinary Orthopaedics and Traumatology) Congress that presented our products related to joint care
The new product presented at this year’s congress was Dysgen™, a DNA chip developed by Bioiberica. Dysgen™ assesses, through a blood sample, the genetic predisposition of a dog to develop Canine Hip Dysplasia (CHD) . Dr. Armand Sánchez from the UAB read a lecture (sponsored by Bioibérica) on the genetic bases of osteoarthritis during the "pre-congress" series of conferences.
The exhibit of Bioiberica’s veterinary division received many visitors interested in that innovative tool as well as in our Cosequin Taste HA range of products.
Our Italian distributor helped us with our exhibit, because this year’s congress has coincided with the Italian SCIVAC congress.
Related News
- This marks yet another step forward in the internalisation strategy of this business unit's dedicated to companion animal health
- The company has launched three products for joint and internal health: Condrovet® Force HA, Calmurofel® and Impromune®
- The study, carried out at the University of Florida, supports the use of this new formulation of sphingolipids and glycosaminoglycans as a strategy to improve skin health in patients with canine atopic dermatitis
- The fourth Iberzoo Propet will be held from 5 to 7 March at the Feria de Madrid
- Klorexivet®, Prolivet® and Condrovet Force HA® are scientifically proven products that bring value added for veterinarians